| scholarly article | Q13442814 |
| P2093 | author name string | Keyvan Moghissi | |
| Ron R Allison | |||
| P2860 | cites work | Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question | Q46056255 |
| Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation | Q67596066 | ||
| Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells | Q68032753 | ||
| Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction | Q68415962 | ||
| Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG) | Q72163249 | ||
| Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo | Q73722498 | ||
| Photodynamic therapy | Q74688364 | ||
| The photobiology of photodynamic therapy: cellular targets and mechanisms | Q77526079 | ||
| Photosensitivity and heat | Q79060658 | ||
| Death and anti-death: tumour resistance to apoptosis | Q28217065 | ||
| Release of prostaglandin E2 from cells by photodynamic treatment in vitro | Q28342103 | ||
| Laser and non-laser light sources for photodynamic therapy | Q30843269 | ||
| Antivascular tumor eradication by hypericin-mediated photodynamic therapy | Q30872532 | ||
| Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor. | Q30981406 | ||
| Photodynamic therapy targeted to tumor-induced angiogenic vessels | Q30988498 | ||
| In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour | Q33178931 | ||
| Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation | Q33208158 | ||
| Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death | Q33939339 | ||
| Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction | Q33939506 | ||
| The photodynamic properties of a particular hematoporphyrin derivative | Q34249150 | ||
| Photodynamic therapy in oncology | Q34390277 | ||
| The role of apoptosis in response to photodynamic therapy: what, where, why, and how. | Q35092776 | ||
| Lasers and light sources for PDT: past, present and future | Q35210416 | ||
| Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). | Q35856416 | ||
| Cooperative effects of photodynamic treatment of cells in microcolonies | Q36021908 | ||
| Role of cytokines in photodynamic therapy-induced local and systemic inflammation | Q36648974 | ||
| Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. | Q36723048 | ||
| Photodiagnosis for cutaneous malignancy: a brief clinical and technical review | Q37438853 | ||
| Future of oncologic photodynamic therapy | Q37763099 | ||
| Photosensitizers in clinical PDT. | Q38232376 | ||
| Clinical PD/PDT in North America: An historical review | Q38232431 | ||
| Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity | Q38273524 | ||
| Future PDT. | Q39926818 | ||
| Photodynamic therapy (PDT) of malignant tumors | Q40201578 | ||
| On the mechanism of the tumour-localising effect in photodynamic therapy | Q40666852 | ||
| The role of lipoproteins in the delivery of tumour-targeting photosensitizers | Q40773646 | ||
| Structure and biodistribution relationships of photodynamic sensitizers | Q41111962 | ||
| The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen | Q41689851 | ||
| Cell death pathways in photodynamic therapy of cancer. | Q43066327 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 24-29 | |
| P577 | publication date | 2013-01-31 | |
| P1433 | published in | Clinical endoscopy | Q26842801 |
| P1476 | title | Photodynamic Therapy (PDT): PDT Mechanisms | |
| P478 | volume | 46 |
| Q37687553 | A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis |
| Q64095603 | Accurate early prediction of tumour response to PDT using optical coherence angiography |
| Q35476065 | Analysis of the in vivo and in vitro effects of photodynamic therapy on breast cancer by using a sensitizer, sinoporphyrin sodium |
| Q52663552 | Antimicrobial Photodynamic therapy enhanced by the peptide aurein 1.2. |
| Q38964181 | Antitumor effect of sinoporphyrin sodium-mediated photodynamic therapy on human esophageal cancer Eca-109 cells |
| Q35685486 | Antitumor effects evaluation of a novel porphyrin derivative in photodynamic therapy |
| Q91658027 | Application of Porphyrins in Antibacterial Photodynamic Therapy |
| Q47755734 | Applications of functionalized nanomaterials in photodynamic therapy. |
| Q39027897 | Ascorbic acid synergistically potentiates phloxine b-induced photocytotoxicity in human acute promyelocytic leukemia cells |
| Q46291379 | Biofilm formation by Candida albicans is inhibited by photodynamic antimicrobial chemotherapy (PACT), using chlorin e6: increase in both ROS production and membrane permeability |
| Q41006050 | Biotinylated Chlorin and Its Zinc and Indium Complexes: Synthesis and In Vitro Biological Evaluation for Photodynamic Therapy |
| Q38834264 | Bleomycin enhances the efficacy of sonodynamic therapy using aluminum phthalocyanine disulfonate |
| Q24658610 | CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells |
| Q92226221 | Comparative analysis of single- and dual-wavelength photodynamic therapy regimes with chlorin-based photosensitizers: animal study |
| Q26782780 | Drug Carrier for Photodynamic Cancer Therapy |
| Q92149904 | Effect of Photodynamic Therapy on Microorganisms Responsible for Dental Caries: A Systematic Review and Meta-Analysis |
| Q60302345 | Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic cancer cells and |
| Q64092567 | Effectiveness of ZnPc and of an amine derivative to inactivate Glioblastoma cells by Photodynamic Therapy: an in vitro comparative study |
| Q88801644 | Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials |
| Q97542745 | Efficacy of ruthenium coordination complex-based Rutherrin in a preclinical rat glioblastoma model |
| Q99403223 | Escherichia coli Sterilization Using a Light-Emitting Diode and Methylene Blue |
| Q36165888 | Evaluation of Hydrogel Suppositories for Delivery of 5-Aminolevulinic Acid and Hematoporphyrin Monomethyl Ether to Rectal Tumors. |
| Q35585754 | Evaluation of a bacteriochlorin-based photosensitizer's anti-tumor effect in vitro and in vivo |
| Q42720170 | Evaluation of photodynamic therapy in adhesion protein expression. |
| Q57426243 | Fluorinated polymer–photosensitizer conjugates enable improved generation of ROS for anticancer photodynamic therapy |
| Q44583167 | Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells. |
| Q60925081 | Functional Polymer Nanocarriers for Photodynamic Therapy |
| Q41545901 | Gold nanoparticles enlighten the future of cancer theranostics. |
| Q60952253 | HSA-Coated Magnetic Nanoparticles for MRI-Guided Photodynamic Cancer Therapy |
| Q35181613 | Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP. |
| Q94474333 | Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy |
| Q26765475 | Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review |
| Q36405909 | New photodynamic therapy with next-generation photosensitizers |
| Q36098492 | Nonpigmented hair removal using photodynamic therapy in animal model. |
| Q30660258 | Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents. |
| Q45006777 | PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology |
| Q27348681 | PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro |
| Q58786646 | Photodynamic Therapy for Metastatic Melanoma Treatment: A Review |
| Q50053143 | Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei. |
| Q40071674 | Photodynamic antimicrobial chemotherapy for Staphylococcus aureus and multidrug-resistant bacterial burn infection in vitro and in vivo |
| Q51149440 | Photodynamic therapy and diagnosis: Principles and comparative aspects. |
| Q37620403 | Photodynamic therapy monitoring with optical coherence angiography |
| Q38170385 | Photodynamic therapy: oncologic horizons |
| Q40602973 | Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand |
| Q46569263 | Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy. |
| Q36939344 | Polymeric Nanoparticle-Based Photodynamic Therapy for Chronic Periodontitis in Vivo |
| Q39310603 | Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents |
| Q35218663 | Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma. |
| Q38247283 | Progress of photodynamic therapy applications in the treatment of musculoskeletal sarcoma (Review). |
| Q37667736 | Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma |
| Q57176306 | Recent Progress in Metal-Based Nanoparticles Mediated Photodynamic Therapy |
| Q47667015 | Recent Progress in Near Infrared Light Triggered Photodynamic Therapy. |
| Q91656899 | Screening of X-ray responsive substances for the next generation of radiosensitizers |
| Q99579667 | Single-atom replacement as a general approach towards visible-light/near-infrared heavy-atom-free photosensitizers for photodynamic therapy |
| Q53199541 | Sonodynamic therapy using 5-aminolevulinic acid enhances the efficacy of bleomycin. |
| Q35867856 | Synthesis and antitumor activity evaluation of a novel porphyrin derivative for photodynamic therapy in vitro and in vivo |
| Q90211812 | Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery |
| Q89736507 | Targeted Nanomaterials for Phototherapy |
| Q89964160 | The Application of DVDMS as a Sensitizing Agent for Sono-/Photo-Therapy |
| Q36001329 | The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro. |
| Q36381529 | Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy |
| Q49803788 | Trifluoromethyl Boron Dipyrromethene Derivatives as Potential Photosensitizers for Photodynamic Therapy |
| Q47975081 | Water-soluble Manganese and Iron Mesotetrakis(carboxyl)porphyrin: DNA Binding, Oxidative Cleavage, and Cytotoxic Activities |
| Q91923945 | mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro |
Search more.